Pfizer Pays $135M To Bow Out Of Marketing Deal
Pfizer Inc. seems to have mended its fraying relationship with partner Nektar Therapeutics by agreeing to pay Nektar $135 million in order to bow out of a marketing agreement the two...To view the full article, register now.
Already a subscriber? Click here to view full article